Zinc Ion

Zinc Ion

SCHEMBL3969310

[O-2].[O-2].[O-2].[Ru+4].[Zn+2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL1395439 1.00 — —
Zinc Ion SCHEMBL19666007 0.87 — —
Zinc Ion SCHEMBL9352514 0.87 — —
Zinc Ion SCHEMBL9727129 0.82 GPR39 (0.33) —
SCHEMBL1727116 0.82 — —
Zinc Ion SCHEMBL10731560 0.82 GPR39 (0.33) —
Zinc Ion SCHEMBL8466026 0.82 GPR39 (0.33) —
Zinc Ion SCHEMBL8045556 0.82 GPR39 (0.33) —
Zinc Ion SCHEMBL21753941 0.82 — —
Zinc Ion SCHEMBL8061086 0.82 GPR39 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009045489-A2 PROCESS FOR THE SYNTHESIS OF CMHTP, A PALIPERIDONE INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-04-09 — — WO claimed
CN-116732497-B Method for depositing ruthenium-containing films on substrates by cyclical deposition processes ASM IP私人控股有限公司 2025-06-17 — — CN disclosed
WO-2009045489-A2 PROCESS FOR THE SYNTHESIS OF CMHTP, A PALIPERIDONE INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2009-04-09 — — WO disclosed
Send feedback